Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Caravaggio

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Schizophrenia Research|March 12, 2015
Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET studyShinichiro Nakajima, Fernando Caravaggio, David C Mamo, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophreniaJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
International Journal of Geriatric Psychiatry|November 8, 2017
Amotivation is associated with smaller ventral striatum volumes in older patients with schizophreniaFernando Caravaggio, Gagan Fervaha, Yusuke Iwata, et al.
Schizophrenia Bulletin Open|May 10, 2021
Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant SchizophreniaYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Frontiers in Psychiatry|December 21, 2018
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in SchizophreniaNicole E MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, et al.
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
The Journal of Clinical Psychiatry|January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With SchizophreniaYusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Schizophrenia Research|September 15, 2020
Apathy is not associated with reduced ventral striatal volume in patients with schizophreniaAchim Burrer, Fernando Caravaggio, Andrei Manoliu, et al.
Neuroimage. Clinical|October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophreniaTakashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Neuroscience and Biobehavioral Reviews|October 31, 2021
Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysisFumihiko Ueno, Yusuke Iwata, Shinichiro Nakajima, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Schizophrenia Research|March 12, 2015
Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET studyShinichiro Nakajima, Fernando Caravaggio, David C Mamo, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophreniaJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
International Journal of Geriatric Psychiatry|November 8, 2017
Amotivation is associated with smaller ventral striatum volumes in older patients with schizophreniaFernando Caravaggio, Gagan Fervaha, Yusuke Iwata, et al.
Schizophrenia Bulletin Open|May 10, 2021
Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant SchizophreniaYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Frontiers in Psychiatry|December 21, 2018
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in SchizophreniaNicole E MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, et al.
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
The Journal of Clinical Psychiatry|January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With SchizophreniaYusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Schizophrenia Research|September 15, 2020
Apathy is not associated with reduced ventral striatal volume in patients with schizophreniaAchim Burrer, Fernando Caravaggio, Andrei Manoliu, et al.
Neuroimage. Clinical|October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophreniaTakashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Neuroscience and Biobehavioral Reviews|October 31, 2021
Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysisFumihiko Ueno, Yusuke Iwata, Shinichiro Nakajima, et al.
Pageof 9